SCHEMBL17297429

SCHEMBL17297429

c1ccc(-c2ccc(-c3ccc4c(c3)c3cc(-c5ccc(-c6ccccc6)cc5)ccc3n4-c3ccc4c(c3)c3cc(-n5c6ccc(-c7ccc(-c8ccccc8)cc7)cc6c6cc(-c7ccc(-c8ccccc8)cc7)ccc65)ccc3n4-c3ccc(-c4nc(-c5ccccc5)nc(-c5ccccc5)n4)cc3)cc2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR3C1 P04150 1/20 0.40
MEN1 O00255 5/20 0.40
KMT2A Q03164 5/20 0.40
MAPT P10636 3/20 0.40
ALDH1A1 P00352 2/20 0.40
HPGD P15428 2/20 0.40
L3MBTL1 Q9Y468 2/20 0.39
KDM4E B2RXH2 2/20 0.39
ATM Q13315 2/20 0.39
RXRA P19793 1/20 0.39
AVPR1A P37288 1/20 0.38
NTSR1 P30989 1/20 0.37
LMNA P02545 1/20 0.36
GLA P06280 1/20 0.36
OXTR P30559 1/20 0.35
RAC2 P15153 1/20 0.35
RAC3 P60763 1/20 0.35
CDC42 P60953 1/20 0.35
RAC1 P63000 1/20 0.35
PTGER4 P35408 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15910200 1.00 NR3C1 (0.40) NR3C1MEN1KMT2AMAPTALDH1A1
SCHEMBL29775080 1.00 NR3C1 (0.40) NR3C1MEN1KMT2AMAPTALDH1A1
SCHEMBL15910204 0.97 NR3C1 (0.39) NR3C1MEN1KMT2AMAPTALDH1A1
SCHEMBL15248555 0.97 NR3C1 (0.42) NR3C1MEN1KMT2AMAPTALDH1A1
SCHEMBL21763739 0.97 NR3C1 (0.42) NR3C1MEN1KMT2AMAPTALDH1A1
SCHEMBL22763780 0.97 NR3C1 (0.42) NR3C1MEN1KMT2AMAPTALDH1A1
SCHEMBL22763388 0.97 NR3C1 (0.42) NR3C1MEN1KMT2AMAPTALDH1A1
SCHEMBL21365764 0.97 NR3C1 (0.42) NR3C1MEN1KMT2AMAPTALDH1A1
SCHEMBL22544982 0.97 NR3C1 (0.42) NR3C1MEN1KMT2AMAPTALDH1A1
SCHEMBL17950355 0.97 NR3C1 (0.42) NR3C1MEN1KMT2AMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2949724-B1 LIGHT EMITTING MATERIAL AND ORGANIC LIGHT EMITTING ELEMENT USING SAME KYULUX INC (JP) 2020-06-17 EP disclosed
US-20150357582-A1 LIGHT EMITTING MATERIAL AND ORGANIC LIGHT EMITTING DEVICE USING SAME KYULUX, INC. (JP) 2015-12-10 US disclosed
EP-2949724-A1 LIGHT EMITTING MATERIAL AND ORGANIC LIGHT EMITTING ELEMENT USING SAME Kyushu University, National University Corporation (JP) 2015-12-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150357582-A1 LIGHT EMITTING MATERIAL AND ORGANIC LIGHT EMITTING DEVICE USING SAME CRY1, CRY2, INTS9 NR3C1 744/4885MEN1 2605/4885KMT2A 3054/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.